Xtl Biopharmaceuticals (XTLB) Cash from Investing Activities (2009 - 2016)
Xtl Biopharmaceuticals' Cash from Investing Activities was $522,000 in the year ended Dec 31, 2025, compared with -$844,000 a year earlier.
Powered by 
Analysis
Xtl Biopharmaceuticals (XTLB) Cash from Investing Activities (2009 - 2016) Analysis & Trends
From the year ended Dec 31, 2009 onward, Xtl Biopharmaceuticals has reported Cash from Investing Activities for 17 years.
- Cash from Investing Activities shows a five-year compound annual growth rate of 74.8% (years ended Dec 2020 to Dec 2025).
- The figure for the year ended Dec 31, 2025 marks the highest annual Cash from Investing Activities since the year ended Dec 31, 2019.
- Per Business Quant data, Cash from Investing Activities in earlier years was -$844,000 in the year ended Dec 31, 2024, $41,000 in the year ended Dec 31, 2023 (+13.9%), $36,000 in the year ended Dec 31, 2022 (+350.0%) and $8,000 in the year ended Dec 31, 2021 (-75.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | -15.40 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | -1.11 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | -1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -5.60 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.11 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -2.91 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | -569.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.35 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.11 Bn |
| 10 | Xtl Biopharmaceuticals | 2.03 Bn | 2.03 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2016 | 1,000.00 |
| Dec 31, 2015 | -54,000.00 |
| Sep 30, 2015 | -63,000.00 |
| Jun 30, 2015 | -14,000.00 |
| Dec 31, 2014 | 516,000.00 |
| Sep 30, 2014 | 116,000.00 |
| Jun 30, 2014 | 538,000.00 |
| Mar 31, 2014 | 279,000.00 |
| Dec 31, 2013 | -945,000.00 |
| Sep 30, 2013 | 3.78 Mn |
| Jun 30, 2013 | -3,000.00 |
| Mar 31, 2013 | 502,000.00 |
| Dec 31, 2012 | -729,000.00 |
| Sep 30, 2012 | 160,000.00 |
| Jun 30, 2012 | -1.62 Mn |
| Mar 31, 2012 | 981,000.00 |
| Dec 31, 2011 | -983,000.00 |
| Sep 30, 2011 | 150,000.00 |
| Jun 30, 2011 | 23,000.00 |
| Mar 31, 2011 | -1.85 Mn |
API Access
Xtl Biopharmaceuticals Cash from Investing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=XTLB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-investing-activities", "ticker": "XTLB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=XTLB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();